Business Wire

PHAXIAM Therapeutics Presents Clinical Data of the PhagoDAIR Pilot Study, With Results Confirming the Design of the GLORIA Phase II Clinical Study

LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...
Business Wire

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

First-of-its-Kind European Pilot Study Shows Improvement in Mood, Energy, and Anxiety—Fueling Hope for a New Mental Health Treatment SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group today announced ...

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)

Initial study will enable further collaboration on the predictive capabilities of StemPrintERPHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage ...
AOL

Pilot Study Using GLP-1 Drugs on Cats Has People Scratching Their Heads: 'Not the Meowzempic'

GLP-1 drugs have been life changing for the humans who need them, whether it's for diabetes, weight loss, or other medical conditions. And now, researchers are trying to determine whether they can ...